Neuroblastoma
📧 Sign up to get email alerts when something new happens for Neuroblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors [EARLY_Phase 1]
A Mayo Clinic-sponsored early-phase 1 trial is evaluating 68Ga-DOTATATE PET/CT as a diagnostic tool for pediatric metastatic neuroendocrine …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma [Phase 1]
Phase 1 clinical trial evaluating GD2-targeted CAR T-cells engineered with IL-15 and inducible caspase-9 for relapsed/refractory neuroblasto…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial [Phase 2]
A Phase II clinical trial (NANT 2021-01) evaluating sequential Temozolomide, Irinotecan, NK cell therapy, and a GD2 monoclonal antibody for …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells [Phase 1]
Phase 1 trial evaluating expanded natural killer (NK) cell immunotherapy for relapsed or refractory neuroblastoma, sponsored by the New Appr…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Neuroblastoma Biology Study
A neuroblastoma biology study led by the New Approaches to Neuroblastoma Therapy Consortium is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma [Phase 1]
A Phase 1 trial evaluating sorafenib in combination with cyclophosphamide/topotecan for relapsed and refractory neuroblastoma; the study sta…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Neuroblastoma Precision Trial
Clinical trial status update for the Neuroblastoma Precision Trial, sponsored by New Approaches to Neuroblastoma Therapy Consortium; the stu…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma [Phase 2]
This clinical trial update describes a Phase 2 study comparing 123I-MIBG and 18F-MFBG imaging in patients with newly diagnosed, high-risk ne…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas [Phase 1]
Phase 1 dose-escalation study of CLR-131 in children with relapsed or refractory malignant tumors, including neuroblastoma and sarcomas, cur…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma [Phase 2]
Phase 2 clinical trial evaluating a vaccine in combination with beta-glucan and GM-CSF in neuroblastoma patients, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating alpha/beta T and B cell depletion with zoledronic acid for solid tumors; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy [Phase 1]
Clinical trial update for the Phase 1 PEACH trial (precision medicine and adoptive cellular therapy) for neuroblastoma and diffuse intrinsic…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors [Phase 2]
This clinical trial update outlines a Phase 2 study evaluating a combination of liposomal irinotecan, vincristine, temozolomide, and anlotin…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma [Phase 2]
A Phase 2 study evaluating the combination of tipifarnib and naxitamab for relapsed/refractory neuroblastoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation [EARLY_Phase 1]
This is a pediatric early-phase 1 trial update evaluating intrathecal topotecan with maintenance chemotherapy for high-risk embryonal centra…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) [Phase 3]
This clinical trial update describes a Phase 3 study evaluating adding 131I-MIBG or lorlatinib to intensive therapy for high-risk neuroblast…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: A Study of Avutometinib for People With Solid Tumor Cancers [Phase 1]
A Phase 1 study of Avutometinib for people with solid tumors, including CNS tumors and NF1-associated tumors, is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for tegavivint in recurrent or refractory solid tumors, including lymphomas and desmoid tumors, currently …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Pediatric Precision Laboratory Advanced Neuroblastoma Therapy [Phase 2]
This document reports an ongoing Phase 2 clinical trial evaluating a pediatric precision laboratory therapy for neuroblastoma that is curren…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow [Phase 2]
Phase 2 clinical trial updating Naxitamab for high-risk neuroblastoma patients with primary refractory disease or incomplete response to sal…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma [Phase 2]
A Phase II clinical trial update describes evaluating the addition of N-803 to a chemoimmunotherapy backbone for relapsed or refractory neur…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma [Phase 2]
This update covers a Phase 2 clinical trial testing reduced chemotherapy combined with monoclonal antibody–based therapy in children with ne…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma [NA]
An ongoing clinical trial update for the Resource Intervention to Support Equity (RISE) study in high-risk neuroblastoma, currently recruiti…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma [Phase 1, Phase 2]
A clinical trial is evaluating the imaging agent Anti-GD2-800CW in patients with neuroblastoma. The study is in Phase 1/2 and currently recr…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Engineering Immune Organoids to Study Pediatric Cancer [NA]
A clinical trial update describes a study using engineered immune organoids to investigate pediatric cancers, including brain tumors, kidney…